August 24, 2017

On August 24, 2017, Broken Coast Cannabis Ltd., a licensed producer of cannabis for medical purposes located in British Columbia, has begun a voluntary Type III recall of 3 lots of dried marijuana that were produced between June to July 2016. The affected lot numbers are found below.
Following the inspection at the Broken Coast Cannabis Ltd. site in March 2017 to conduct random sampling of cannabis products, a test result for a cannabis oil sample in July 2017 showed the presence of myclobutanil and spinosad, at levels below quantifiable limits.
This resulted in further sampling of cannabis products from the licensed producer site where a cannabis leaf sample indicated the presence of myclobutanil at a level of 0.017 parts per million (ppm). The licensed producer undertook further testing of their products through a third party laboratory, which indicated the presence of myclobutanil. As a result, Broken Coast Cannabis Ltd. is recalling three lots of dried marijuana sold between July and December 2016.